Medicine and Dentistry
Chronic Pancreatitis
85%
Vagus Nerve Stimulation
51%
Chronic Pain
42%
Metabolite
32%
Insulin Dependent Diabetes Mellitus
28%
Telerehabilitation
28%
Heart Failure
28%
Controlled Clinical Trial
28%
Pain in Chronic Pancreatitis
28%
Polyneuropathy
28%
Clinical Trial
28%
Nociception
28%
Disease Predisposition
28%
Glutamic Acid
28%
Diabetes
22%
Sham Procedure
20%
Abdominal Pain
20%
Sensitization
20%
Sensation
19%
Thalamus
19%
Symptom
17%
Quality of Life
17%
Clinical Endpoint
16%
Magnetic Resonance Imaging
15%
Quantitative Sensory Testing
15%
Cingulate Cortex
14%
Anterior Cingulate
14%
Alpha Wave
14%
Sensory System
14%
Capsaicin
14%
Clinical Population
14%
Sensorimotor Cortex
14%
Brain Areas
14%
Nuclear Magnetic Resonance Spectroscopy
13%
Randomized Controlled Trial
10%
Physical Capacity
10%
Voxel-Based Morphometry
9%
Peripheral Neuropathy
9%
Gray Matter
9%
Electrostimulation
9%
Neuropathy
9%
Synaptic Transmission
9%
Pain Threshold
9%
Pathophysiology
9%
Cross Sectional Study
9%
Diabetic Neuropathy
9%
Clinical Pain
9%
Visual Analog Scale
7%
Analgesia
7%
Pain (Symptom)
7%
Neuroscience
Gray Matter
100%
Vagus Nerve Stimulation
85%
Neuromodulation
57%
Functional Connectivity
57%
Peripheral Neuropathy
42%
Glutamic Acid
42%
Thalamus
38%
Brain Areas
35%
Anterior Cingulate Cortex
32%
Electroencephalography
28%
Capsaicin
28%
Individual Differences
28%
Polyneuropathy
28%
Nociception
28%
Magnetic Resonance Imaging
24%
Nuclear Magnetic Resonance Spectroscopy
23%
Quantitative Sensory Testing
21%
Diabetic Neuropathy
20%
Peripheral Neuropathy
20%
Middle Frontal Gyrus
19%
Superior Longitudinal Fasciculus
19%
Default Mode Network
17%
Synaptic Transmission
14%
Pain Threshold
14%
Voxel-Based Morphometry
14%
Central Nervous System
13%
Putamen
13%
Pain Central Mechanisms
12%
Crossover Study
10%
Brain Plasticity
7%
Superior Temporal Gyrus
7%
Magnetic Resonance Imaging
7%
Pain Pathway
7%
Gyri
7%
Functional Magnetic Resonance Imaging
6%
Opiate
5%
Inferior Longitudinal Fasciculus
5%
Prefrontal Cortex
5%
Keyphrases
Chronic Pancreatitis
57%
Sham Control
28%
Neuromodulation
28%
Controlled Clinical Trial
28%
Scoping Review
28%
Heart Failure Management
28%
White Matter Microstructure
28%
Chronic Pain
28%
Disease Pattern
28%
Transcutaneous
28%
Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)
28%
Brain Morphology
28%
Alpha Frequency
28%
Telerehabilitation
28%
Crossover Clinical Trial
28%
Thalamic Volume
28%
Sham Treatment
24%
Gray Matter Volume
21%
Pain Score
14%
Clinical Endpoints
14%
Alcoholic
10%
Volume Loss
10%
Brain Structure
10%
γ-core
10%
Randomized Controlled Trial
10%
Physical Capacity
10%
Visual Analog Scale
9%
Pain Relief
9%
Vagus Nerve Stimulation
9%
Heart Rate
9%
Tetanic Stimulation
8%
Thalamic Atrophy
8%
Superior Longitudinal Fasciculus
8%
White Matter Tracts
8%
Middle Frontal Gyrus
8%
Quality of Life
7%
Healthy Controls
7%
Etiology
7%
Neuronal Communication
5%
Metabolite Ratios
5%
Inferior Longitudinal Fasciculus
5%
Microstructural Abnormalities
5%
Personalized Approach
5%
Sham Device
5%
Active Transcutaneous
5%
Morphological Brain Changes
5%
Superior Temporal Gyrus
5%
Depressive Symptoms
5%
Patient Well-being
5%
Heart Failure
5%